Skip to main content

Hudson Bay Capital Management LP

Position in GILD — Gilead Sciences, Inc.

CIK 1393825 STAMFORD, CT

Position in GILD

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$13,938,393
-$2,861,153 QoQ
Shares Held
100,010
-26.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2025
CallValue
$46,065,000
CallShares
415,000
PutValue
$34,965,000
PutShares
315,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Hudson Bay Capital Management LP holds $179,007,948 across 10 Drug Manufacturers - General names. GILD ranks #4 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 GILD
Gilead Sciences, Inc.
This page
100,010 $13,938,393

All Filings in GILD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,938,393 100,010
2025-12-31 $16,799,546 136,871
2025-09-30 $34,965,000 315,000
2025-09-30 $46,065,000 415,000
2025-09-30 $1,333,554 12,014
2025-06-30 $1,031,091 9,300
2025-06-30 $31,753,168 286,400
2025-06-30 $2,707,999 24,425
2025-03-31 $5,905,035 52,700
2025-03-31 $14,715,078 131,326
2025-03-31 $29,682,045 264,900
2024-12-31 $10,160,700 110,000
2024-09-30 $9,222,400 110,000
2024-09-30 $6,778,715 80,853
2024-06-30 $9,948,450 145,000
2024-03-31 $34,728,411 474,108
2023-12-31 $3,847,975 47,500
2023-09-30 $18,547,650 247,500
2023-06-30 $4,192,608 54,400
2022-06-30 $1,545,250 25,000
2020-12-31 $2,039,100 35,000
2020-09-30 $5,371,150 85,000